Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Mar;133(3):e91-e97.
doi: 10.1016/j.amjmed.2019.10.005. Epub 2019 Nov 6.

Chronic Chikungunya Arthritis and Rheumatoid Arthritis: What They Have in Common

J Kennedy Amaral  1 , Joshua B Bilsborrow  2 , Robert T Schoen  2
Affiliations
Review

Chronic Chikungunya Arthritis and Rheumatoid Arthritis: What They Have in Common

J Kennedy Amaral et al. Am J Med. 2020 Mar.

Abstract

Chikungunya virus (CHIKV) is a single-stranded RNA virus belonging to the family Togaviridae and genus Alphavirus that causes an acute febrile illness, chikungunya fever, which is transmitted to humans by Aedes species mosquitoes. During acute illness, patients have high fever, polyarthralgias or polyarthritis, maculopapular rash, headache, and myalgia that lasts for days to weeks. Following resolution of acute infection, a significant proportion of patients develop chronic chikungunya arthritis that can resemble rheumatoid arthritis. In this review, we first consider the historical background of infectious causes of inflammatory arthritis, and then the pathogenic and clinical manifestations of chronic chikungunya arthritis as a rheumatoid arthritis mimic. We believe that chronic chikungunya arthritis may be a postinfectious inflammatory process, and that an understanding of the parallels and differences between chronic chikungunya arthritis and rheumatoid arthritis may offer insights into better diagnosis and treatment of both diseases.

Keywords: Chikungunya; Methotrexate; Pathogeneses; Rheumatoid arthritis; Virus.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The authors declare no conflicts of interest.

Figures

Figure 1.
Figure 1.
Pain scores at W0 and W4 in patients treated with MTX for CCA (as observed data). NRS indicates numerical rating scale.
See this image and copyright information in PMC

References

    1. Wimalasiri-Yapa BM, Stassen L, Huang X, Hafner LM, Hu W, Devine GJ et al. (2019). Chikungunya virus in Asia – Pacific: a systematic review. Emerging Microbes & Infections, 8(1), 70–79. doi:10.1080/22221751.2018.1559708 - DOI - PMC - PubMed
    1. LaBeaud A, Bashir F, King CH (2011). Measuring the burden of arboviral diseases: the spectrum of morbidity and mortality from four prevalent infections. Population Health Metrics, 9(1). doi:10.1186/1478-7954-9-1 - DOI - PMC - PubMed
    1. Paul BJ, and Sadanand S (2018). Chikungunya Infection: A Re-emerging Epidemic. Rheumatology and Therapy, 5(2), 317–326. doi:10.1007/s40744-018-0121-7 - DOI - PMC - PubMed
    1. Weaver SC, and Lecuit M Chikungunya virus and the global spread of a mosquito-borne disease. N Engl J Med 2015;372:1231–9 - PubMed
    1. Thiberville S, Moyen N, Dupuis-Maguiraga L, Nougairede A, Gould EA, Roques P, et al. (2013). Chikungunya fever: Epidemiology, clinical syndrome, pathogenesis and therapy. Antiviral Research, 99(3), 345–370. doi:10.1016/j.antiviral.2013.06.009 - DOI - PMC - PubMed

MeSH terms